Schiff R - Search Results

1

Dual roles for coactivator activator and its counterbalancing isoform coactivator modulator in human kidney cell tumorigenesis.

Kang YK, Schiff R, Ko L, Wang T, Tsai SY, Tsai MJ, O'Malley BW. Kang YK, et al. Among authors: schiff r. Cancer Res. 2008 Oct 1;68(19):7887-96. doi: 10.1158/0008-5472.CAN-08-1734. Cancer Res. 2008. PMID: 18829545 Free PMC article.

2

Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer.

Fuqua SA, Schiff R, Parra I, Friedrichs WE, Su JL, McKee DD, Slentz-Kesler K, Moore LB, Willson TM, Moore JT. Fuqua SA, et al. Among authors: schiff r. Cancer Res. 1999 Nov 1;59(21):5425-8. Cancer Res. 1999. PMID: 10554010

3

Estrogen receptor beta protein in human breast cancer: correlation with clinical tumor parameters.

Fuqua SA, Schiff R, Parra I, Moore JT, Mohsin SK, Osborne CK, Clark GM, Allred DC. Fuqua SA, et al. Among authors: schiff r. Cancer Res. 2003 May 15;63(10):2434-9. Cancer Res. 2003. PMID: 12750263 Free PMC article.

4

Estrogen-mediated down-regulation of E-cadherin in breast cancer cells.

Oesterreich S, Deng W, Jiang S, Cui X, Ivanova M, Schiff R, Kang K, Hadsell DL, Behrens J, Lee AV. Oesterreich S, et al. Among authors: schiff r. Cancer Res. 2003 Sep 1;63(17):5203-8. Cancer Res. 2003. PMID: 14500345

5

Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer.

Shou J, Massarweh S, Osborne CK, Wakeling AE, Ali S, Weiss H, Schiff R. Shou J, et al. Among authors: schiff r. J Natl Cancer Inst. 2004 Jun 16;96(12):926-35. doi: 10.1093/jnci/djh166. J Natl Cancer Inst. 2004. PMID: 15199112

6

Endocrinology and hormone therapy in breast cancer: new insight into estrogen receptor-alpha function and its implication for endocrine therapy resistance in breast cancer.

Schiff R, Osborne CK. Schiff R, et al. Breast Cancer Res. 2005;7(5):205-11. doi: 10.1186/bcr1287. Epub 2005 Jul 20. Breast Cancer Res. 2005. PMID: 16168139 Free PMC article.

7

The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth.

Divisova J, Kuiatse I, Lazard Z, Weiss H, Vreeland F, Hadsell DL, Schiff R, Osborne CK, Lee AV. Divisova J, et al. Among authors: schiff r. Breast Cancer Res Treat. 2006 Aug;98(3):315-27. doi: 10.1007/s10549-006-9168-1. Epub 2006 Mar 16. Breast Cancer Res Treat. 2006. PMID: 16541323

8

Treatment of human epidermal growth factor receptor 2-overexpressing breast cancer xenografts with multiagent HER-targeted therapy.

Arpino G, Gutierrez C, Weiss H, Rimawi M, Massarweh S, Bharwani L, De Placido S, Osborne CK, Schiff R. Arpino G, et al. Among authors: schiff r. J Natl Cancer Inst. 2007 May 2;99(9):694-705. doi: 10.1093/jnci/djk151. J Natl Cancer Inst. 2007. PMID: 17470737

9

The dynamics of estrogen receptor status in breast cancer: re-shaping the paradigm.

Lopez-Tarruella S, Schiff R. Lopez-Tarruella S, et al. Among authors: schiff r. Clin Cancer Res. 2007 Dec 1;13(23):6921-5. doi: 10.1158/1078-0432.CCR-07-1399. Clin Cancer Res. 2007. PMID: 18056165 No abstract available.

10

Development of resistance to targeted therapies transforms the clinically associated molecular profile subtype of breast tumor xenografts.

Creighton CJ, Massarweh S, Huang S, Tsimelzon A, Hilsenbeck SG, Osborne CK, Shou J, Malorni L, Schiff R. Creighton CJ, et al. Among authors: schiff r. Cancer Res. 2008 Sep 15;68(18):7493-501. doi: 10.1158/0008-5472.CAN-08-1404. Cancer Res. 2008. PMID: 18794137 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

378 results

Search Page

Filters